NCT01872897View on ClinicalTrials.gov

Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 2, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Gastroesophageal Reflux Disease
Interventions
DRUG

Sodium Alginate Double Action Chewable Tablets

4 tablets as a single dose

DRUG

Placebo

4 tablets as a single dose

Trial Locations (1)

Unknown

RB Investigational Sites, Shanghai

All Listed Sponsors
lead

Reckitt Benckiser Healthcare (UK) Limited

INDUSTRY

NCT01872897 - Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD Patients | Biotech Hunter | Biotech Hunter